000 01456 a2200385 4500
005 20250514031452.0
264 0 _c20020823
008 200208s 0 0 eng d
022 _a0929-8673
024 7 _a10.2174/0929867024606911
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSzekeres, Thomas
245 0 0 _aBenzamide riboside, a recent inhibitor of inosine 5'-monophosphate dehydrogenase induces transferrin receptors in cancer cells.
_h[electronic resource]
260 _bCurrent medicinal chemistry
_cApr 2002
300 _a759-64 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntigens, CD
_xmetabolism
650 0 4 _aAntigens, Differentiation, B-Lymphocyte
_xmetabolism
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aHL-60 Cells
650 0 4 _aHumans
650 0 4 _aIMP Dehydrogenase
_xantagonists & inhibitors
650 0 4 _aIron
_xmetabolism
650 0 4 _aLeukemia, Myeloid
_xdrug therapy
650 0 4 _aNucleosides
_xpharmacology
650 0 4 _aReceptors, Transferrin
_xmetabolism
650 0 4 _aRibavirin
_xanalogs & derivatives
650 0 4 _aTumor Cells, Cultured
700 1 _aSedlak, Jan
700 1 _aNovotny, Ladislav
773 0 _tCurrent medicinal chemistry
_gvol. 9
_gno. 7
_gp. 759-64
856 4 0 _uhttps://doi.org/10.2174/0929867024606911
_zAvailable from publisher's website
999 _c11868297
_d11868297